ABBV Abbvie Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ABBV

Price (delayed)

$251.28

Market cap

$443.96B

P/E Ratio

123.78

Dividend/share

$6.83

EPS

$2.03

Enterprise value

$507.43B

?
Relative Growth: Rel. Growth: 30
Relative Strength: Rel. Strength: 70
Relative Valuation: Rel. Valuation: 14
Relative Profitability: Rel. Profitability: 51

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable ...

Highlights
The quick ratio has grown by 27% from the previous quarter and by 8% YoY
ABBV's revenue is up by 10% year-on-year and by 2.7% since the previous quarter
ABBV's P/E is 113% above its 5-year quarterly average of 58.1 and 6% above its last 4 quarters average of 116.4
Abbvie's equity has plunged by 102% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.abbvie.com
Peers: PFE BMY LLY AMGN

Key stats

What are the main financial stats of ABBV

ABBV stock price

How has the Abbvie stock price performed over time
Intraday
0.14%
1 week
-2.19%
1 month
-3.75%
1 year
28.72%
YTD
9.97%
QTD
-0.14%

Financial performance

How have Abbvie's revenue and profit performed over time
Revenue
$62.82B
Gross profit
$44.4B
Operating income
$15.33B
Net income
$3.64B
Gross margin
70.7%
Net margin
5.8%
The operating income has soared by 52% YoY
The operating margin rose by 39% year-on-year
The net margin has declined by 21% year-on-year and by 16% since the previous quarter
The company's net income fell by 14% QoQ and by 13% YoY

Price vs fundamentals

How does ABBV's price correlate with its fundamentals

Growth

What is Abbvie's growth rate over time

Valuation

What is Abbvie stock price valuation
ABBV P/E details
P/E
123.78
P/B
N/A
P/S
7.08
EV/EBIT
58.91
EV/EBITDA
30.48
EV/Sales
8.08
ABBV's P/E is 113% above its 5-year quarterly average of 58.1 and 6% above its last 4 quarters average of 116.4
The EPS has contracted by 14% from the previous quarter and by 14% YoY
Abbvie's equity has plunged by 102% from the previous quarter
ABBV's P/S is 33% above its 5-year quarterly average of 5.3 and 12% above its last 4 quarters average of 6.3
ABBV's revenue is up by 10% year-on-year and by 2.7% since the previous quarter

Efficiency

How efficient is Abbvie business performance
Abbvie's ROIC has increased by 37% YoY but it has decreased by 7% from the previous quarter
The ROS has grown by 32% YoY but it has contracted by 9% from the previous quarter
Abbvie's return on assets has decreased by 13% QoQ and by 10% YoY

Dividends

What is ABBV's dividend history
Dividend details
DPS
$6.83
Dividend yield
2.72%
Payout ratio
336.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Abbvie financials performed over time
Abbvie's total assets is 4.7% lower than its total liabilities
The quick ratio has grown by 27% from the previous quarter and by 8% YoY
ABBV's current ratio is up by 19% since the previous quarter and by 5% year-on-year
The company's debt to equity has shrunk by 122% YoY but it rose by 47% QoQ
Abbvie's equity has plunged by 102% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.